The 340B discount program—which requires manufacturers to provide outpatient drugs to eligible health care entities at sharply reduced prices—continues to be both controversial and confusing. Manatt’s new webinar will explain the latest developments in the 340B program, including: The impact the drug pricing provisions in the Inflation Reduction Act will have on the 340B program […]
Manatt Health, NYU Law and NYU Wagner lead a panel of health care, business and government leaders—including Amanda Goltz, US Health Care Lead for Worldwide Public Sector Health Care Venture Capital and Startups, Amazon; Gerald Harmon, MD, president of the American Medical Association; and Micky Tripathi, PhD, National Coordinator for Health Information Technology at the […]
What levers of change can the Biden administration use to advance its vision of greater health equity, expanded access to coverage and care, and improved outcomes? What can we expect in 2022 and beyond as the administration pursues its goal of reshaping the health care landscape? In a new webinar from Manatt Health, NYU Law […]
